Vectivbio Holding Ag (VECT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VECT | AMGN | BMY | VRTX | GILD |
| Company | Vectivbio Holding Ag | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 16.80 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 16.88 | 290.58 | 58.48 | 455.43 | 89.94 |
| Low | 16.80 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 16.85 | 290.50 | 58.27 | 449.43 | 89.70 |
| Change | unch | +2.63 | +0.39 | -1.80 | +1.07 |
| % Change | unch | +0.91% | +0.67% | -0.40% | +1.21% |
| Volume | 130,400 | 1,757,170 | 4,477,925 | 821,163 | 2,126,864 |
| 20-Day Average Volume | 1,118,975 | 2,829,711 | 12,238,385 | 1,310,696 | 7,428,200 |
| Previous Close | 16.85 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.81 | 307.43 | 55.93 | 479.25 | 90.88 |
| 20-Day Raw Stochastic | 83.33% | 27.77% | 70.60% | 7.40% | 26.76% |
| 20-Day Relative Strength | 70.95% | 36.73% | 60.98% | 40.97% | 53.04% |
| Weighted Alpha | +163.50 | +2.06 | +26.42 | +18.17 | +25.58 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.41% since 06/29/23 | -1.94% since 11/14/24 | -0.25% since 11/14/24 | -6.88% since 11/14/24 | -2.82% since 11/14/24 |
| Low | 16.20 on 07/03/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 16.94 on 06/30/23 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +1.08% since 06/07/23 | -8.38% since 10/21/24 | +11.96% since 10/21/24 | -5.74% since 10/21/24 | +3.73% since 10/21/24 |
| Low | 16.20 on 07/03/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 16.98 on 06/29/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +84.96% since 04/06/23 | -11.84% since 08/21/24 | +20.47% since 08/21/24 | -7.29% since 08/21/24 | +19.14% since 08/21/24 |
| Low | 8.02 on 04/14/23 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 16.98 on 06/29/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +89.54% since 01/06/23 | -7.83% since 05/21/24 | +38.05% since 05/21/24 | +1.96% since 05/21/24 | +33.02% since 05/21/24 |
| Low | 7.00 on 01/24/23 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 16.98 on 06/29/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 573,237 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 34,020 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 27,340,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -93,740,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.11 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 04/17/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |